Innoviva, Inc. financial data

Symbol
INVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1350 Old Bayshore Highway, Suite 400, Burlingame, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
THERAVANCE INC (to 12/7/2015), ADVANCED MEDICINE INC (to 8/2/2000)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 894 % +160%
Quick Ratio 115 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.4M shares -4.67%
Common Stock, Shares, Outstanding 62.8M shares -4.6%
Entity Public Float 924M USD -99.9%
Common Stock, Value, Issued 628K USD -4.7%
Weighted Average Number of Shares Outstanding, Basic 63.2M shares -6.79%
Weighted Average Number of Shares Outstanding, Diluted 84.5M shares -5.86%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 312M USD -1.91%
Research and Development Expense 25.2M USD -47.7%
General and Administrative Expense 24.2M USD +28%
Costs and Expenses 114M USD +231%
Operating Income (Loss) 359M USD +4.09%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 198M USD -30.1%
Income Tax Expense (Benefit) 16.7M USD -74.7%
Earnings Per Share, Basic 2.82 USD/shares -15.8%
Earnings Per Share, Diluted 2.24 USD/shares -13.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 178M USD +23.8%
Inventory, Net 37.4M USD -24.6%
Other Assets, Current 2.99M USD +5.88%
Assets, Current 311M USD +5.03%
Deferred Income Tax Assets, Net 4.95M USD
Property, Plant and Equipment, Net 324K USD +80%
Operating Lease, Right-of-Use Asset 2.27M USD -23.7%
Intangible Assets, Net (Excluding Goodwill) 224M USD -9.83%
Goodwill 17.9M USD -35.9%
Other Assets, Noncurrent 3.11M USD -20.1%
Assets 1.27B USD +12.2%
Accounts Payable, Current 890K USD -85%
Employee-related Liabilities, Current 3.42M USD -19%
Liabilities, Current 29.9M USD -21.7%
Deferred Income Tax Liabilities, Net 3.81M USD -29.4%
Operating Lease, Liability, Noncurrent 1.3M USD -37.9%
Other Liabilities, Noncurrent 71.7M USD +2.21%
Retained Earnings (Accumulated Deficit) 11.3M USD
Stockholders' Equity Attributable to Parent 566M USD +36.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 704M USD +25.3%
Liabilities and Equity 1.27B USD +12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37M USD +44.2%
Net Cash Provided by (Used in) Financing Activities -9.17M USD +93.3%
Net Cash Provided by (Used in) Investing Activities -43M USD -20.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 62.8M shares -4.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.2M USD +89.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 178M USD +23.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.18M USD -16.5%
Deferred Tax Assets, Valuation Allowance 169M USD +16.9%
Deferred Tax Assets, Gross 228M USD +12.4%
Operating Lease, Liability 2.57M USD -23.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 180M USD -16%
Lessee, Operating Lease, Liability, to be Paid 2.77M USD -25.3%
Operating Lease, Liability, Current 1.27M USD +0.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 143K USD -88.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.43M USD +12.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 3.24M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 200K USD -41.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 149K USD
Deferred Tax Assets, Operating Loss Carryforwards 182M USD +21.6%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 6.59M USD -74.7%
Current Income Tax Expense (Benefit) 9.98M USD -75.8%
Preferred Stock, Shares Authorized 230K shares 0%
Unrecognized Tax Benefits 19.4M USD +19.1%
Operating Lease, Payments 320K USD -17.7%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.18M USD +369%
Current Federal Tax Expense (Benefit) 7.8M USD -80.9%
Amortization of Intangible Assets 24.4M USD +160%
Depreciation, Depletion and Amortization 3.5M USD +1.19%
Deferred Tax Assets, Net of Valuation Allowance 58.7M USD +1.11%
Share-based Payment Arrangement, Expense 5.69M USD -28.7%
Deferred State and Local Income Tax Expense (Benefit) -2.19M USD -251%
Interest Expense 20.6M USD +19.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%